SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Iovance Biotherapeutics at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Iovance Biotherapeutics brings 2 presentations to SITC 2026 in Phoenix, and exhibits at Booth 700. Its program centres on lifileucel, its therapy made from tumor-infiltrating lymphocytes, and on the regulatory framework for new immunotherapy drugs. A concrete piece compares long-term survival on lifileucel with standard care in advanced melanoma that no longer responds to anti-PD-1 drugs, using real-world US data.

OrganizationSITC 2026 Attendance
Biotech
Develops and commercializes tumor-infiltrating lymphocyte (TIL) cell therapies for people with solid tumors.
Booth
Exhibiting at Booth 700
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Session
Wed Nov 4
4:10pm–4:55pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Iovance Biotherapeutics

Tell us what you sell and we’ll find the people at Iovance Biotherapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction